SARS-CoV-2 Mpro oligomerization as a potential target for therapy
Kinga Lis, Jacek Plewka, Filipe Menezes, Ewa Bielecka, Yuliya Chykunova, Katarzyna Pustelny, Stephan Niebling, Angelica Struve García, María García-Alai, Grzegorz M. Popowicz, Anna Czarna, Tomasz Kantyka, Krzysztof Pyrć
Topics & Concepts
ProteaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyChemistryComputational biologyBiologyMedicineBiochemistryEnzymeInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchBacteriophages and microbial interactionsVirus-based gene therapy research